EHA 2023 | The impact of symptoms on QoL in patients with MPNs
Marina Kremyanskaya
• 10 Jun 2023
Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York City, NY, discusses the impact of symptoms on the quality of life (QoL) of patients with myeloproliferative neoplasms (MPNs), highlighting the need to develop therapies and supportive care for symptom control. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultant to Protagonist, Abbvie, CTI, Morphosys
